Estimating health care costs related to cancer treatment from SEER-Medicare data.

Martin L. Brown, Gerald F. Riley, Nicki Schussler, Ruth Etzioni

Research output: Contribution to journalArticle

345 Citations (Scopus)

Abstract

BACKGROUND: Cancer-specific medical care costs are used by health service researchers, medical decision analysts, and health care policymakers. The SEER-Medicare database is a unique data resource that makes it possible to derive incidence- and prevalence-based estimates of cancer-related medical care costs by site and stage of disease, by treatment approach, and for age and gender strata for individuals older than 65 years. OBJECTIVES: This paper describes the cost-related data available in the SEER-Medicare database, and discusses techniques and methods that have been used to derive various cost estimates from these data. The limitations of SEER-Medicare data as a source of cost estimates are also discussed. RESULTS: Examples of cost estimates for colorectal and breast cancer derived from SEER-Medicare are presented, including estimates of incidence-based cost (average cost per patient) by the initial, terminal, and continuing care phases of cancer treatment. Estimates of cancer-related treatment costs, costs by type of treatment, and long-term costs are presented, as are prevalence-based costs (aggregate Medicare and national expenditures) by cancer type.

Original languageEnglish (US)
JournalMedical care
Volume40
Issue number8 Suppl
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Second Primary Neoplasms
Medicare
Health Care Costs
Costs and Cost Analysis
Neoplasms
Databases
Terminal Care
Incidence
Health Expenditures
Health Services
Colorectal Neoplasms
Research Personnel
Breast Neoplasms
Delivery of Health Care
Therapeutics

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Brown, M. L., Riley, G. F., Schussler, N., & Etzioni, R. (2002). Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical care, 40(8 Suppl).

Estimating health care costs related to cancer treatment from SEER-Medicare data. / Brown, Martin L.; Riley, Gerald F.; Schussler, Nicki; Etzioni, Ruth.

In: Medical care, Vol. 40, No. 8 Suppl, 01.01.2002.

Research output: Contribution to journalArticle

Brown, ML, Riley, GF, Schussler, N & Etzioni, R 2002, 'Estimating health care costs related to cancer treatment from SEER-Medicare data.', Medical care, vol. 40, no. 8 Suppl.
Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical care. 2002 Jan 1;40(8 Suppl).
Brown, Martin L. ; Riley, Gerald F. ; Schussler, Nicki ; Etzioni, Ruth. / Estimating health care costs related to cancer treatment from SEER-Medicare data. In: Medical care. 2002 ; Vol. 40, No. 8 Suppl.
@article{abde209819174814a8b2f90588ed1d33,
title = "Estimating health care costs related to cancer treatment from SEER-Medicare data.",
abstract = "BACKGROUND: Cancer-specific medical care costs are used by health service researchers, medical decision analysts, and health care policymakers. The SEER-Medicare database is a unique data resource that makes it possible to derive incidence- and prevalence-based estimates of cancer-related medical care costs by site and stage of disease, by treatment approach, and for age and gender strata for individuals older than 65 years. OBJECTIVES: This paper describes the cost-related data available in the SEER-Medicare database, and discusses techniques and methods that have been used to derive various cost estimates from these data. The limitations of SEER-Medicare data as a source of cost estimates are also discussed. RESULTS: Examples of cost estimates for colorectal and breast cancer derived from SEER-Medicare are presented, including estimates of incidence-based cost (average cost per patient) by the initial, terminal, and continuing care phases of cancer treatment. Estimates of cancer-related treatment costs, costs by type of treatment, and long-term costs are presented, as are prevalence-based costs (aggregate Medicare and national expenditures) by cancer type.",
author = "Brown, {Martin L.} and Riley, {Gerald F.} and Nicki Schussler and Ruth Etzioni",
year = "2002",
month = "1",
day = "1",
language = "English (US)",
volume = "40",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",
number = "8 Suppl",

}

TY - JOUR

T1 - Estimating health care costs related to cancer treatment from SEER-Medicare data.

AU - Brown, Martin L.

AU - Riley, Gerald F.

AU - Schussler, Nicki

AU - Etzioni, Ruth

PY - 2002/1/1

Y1 - 2002/1/1

N2 - BACKGROUND: Cancer-specific medical care costs are used by health service researchers, medical decision analysts, and health care policymakers. The SEER-Medicare database is a unique data resource that makes it possible to derive incidence- and prevalence-based estimates of cancer-related medical care costs by site and stage of disease, by treatment approach, and for age and gender strata for individuals older than 65 years. OBJECTIVES: This paper describes the cost-related data available in the SEER-Medicare database, and discusses techniques and methods that have been used to derive various cost estimates from these data. The limitations of SEER-Medicare data as a source of cost estimates are also discussed. RESULTS: Examples of cost estimates for colorectal and breast cancer derived from SEER-Medicare are presented, including estimates of incidence-based cost (average cost per patient) by the initial, terminal, and continuing care phases of cancer treatment. Estimates of cancer-related treatment costs, costs by type of treatment, and long-term costs are presented, as are prevalence-based costs (aggregate Medicare and national expenditures) by cancer type.

AB - BACKGROUND: Cancer-specific medical care costs are used by health service researchers, medical decision analysts, and health care policymakers. The SEER-Medicare database is a unique data resource that makes it possible to derive incidence- and prevalence-based estimates of cancer-related medical care costs by site and stage of disease, by treatment approach, and for age and gender strata for individuals older than 65 years. OBJECTIVES: This paper describes the cost-related data available in the SEER-Medicare database, and discusses techniques and methods that have been used to derive various cost estimates from these data. The limitations of SEER-Medicare data as a source of cost estimates are also discussed. RESULTS: Examples of cost estimates for colorectal and breast cancer derived from SEER-Medicare are presented, including estimates of incidence-based cost (average cost per patient) by the initial, terminal, and continuing care phases of cancer treatment. Estimates of cancer-related treatment costs, costs by type of treatment, and long-term costs are presented, as are prevalence-based costs (aggregate Medicare and national expenditures) by cancer type.

UR - http://www.scopus.com/inward/record.url?scp=0036676214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036676214&partnerID=8YFLogxK

M3 - Article

C2 - 12187175

AN - SCOPUS:0036676214

VL - 40

JO - Medical Care

JF - Medical Care

SN - 0025-7079

IS - 8 Suppl

ER -